Mass General Brigham Incorporated
Location
Massachusetts
Founded
1994-02-13
Risk Signals
1496 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., General Medical and Surgical Hospitals), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Mass General Brigham Incorporated
Live alerts from global media, monitored by Business Radar
2025-04-27 (scitechdaily.com)
AI Predicts Pediatric Brain Tumor Relapse With Surprising Accuracy
Researchers have developed an AI system that predicts brain tumor recurrence in children using sequential MRI scans. By applying a novel "temporal learning" method that processes multiple post-treatment images, the AI significantly outperforms traditional single-scan models. The approach promises
Read more
2025-04-25 (it-boltwise.de)
AI predicts the return of brain tumors in children
A new AI technology predicts the return of brain tumors in children and could revolutionize medical surveillance.
Read more
2025-04-24 (synbiobeta.com)
Bespoke CRISPR Enzymes Generated By AI for a Safer Genetic Future -
A new algorithm can predict the properties of 64 million CRISPR enzymes—making gene editing safer and more precise
Read more
2025-04-24 (sciencedaily.com)
Artificial intelligence tool helps predict relapse of pediatric brain cancer |
Researchers trained and validated a deep learning model that can detect subtle changes across post-treatment brain scans and forecast glioma recurrence with up to 89 percent accuracy.
Read more
2025-04-20 (lifeboat.com)
Scientists Develop New Gene Editing Tool that Replaces Entire Genes – News: The Blog
Scientists from Mass General Brigham and Beth Israel Deaconess Medical Center have developed a novel gene editing tool called STITCHR. Unlike traditional CRISPR, STITCHR inserts entire genes at precise locations, minimizing unintended mutations. This gene editing tool simplifies use and offers potential as a one-time treatment for genetic disorders. The technology uses retrotransposons, naturally occurring "jumping genes" found in all eukaryotic organisms, which can move and integrate into genomes. Using computational screening, the researchers identified and reprogrammed a specific retrotransposon to work with the nickase enzyme from CRISPR, forming the complete STITCHR system that allows a precise, seamless gene insertion into the genome. STITCHR offers the potential to replace or supplement entire genes, creating a more universal treatment option for various genetic diseases. The research team is now working to improve its efficiency and move it toward clinical use.
Read more
2025-03-27 (bio.org)
Enabling Gene and Cell Therapy translation from bench to clinic at Mass General Brigham's Gene and Cell Therapy Institute (MGB-GCTI) - International Convention 2025
With more than 30 approved gene and cell therapy (GCT) products and the rapid emergence of new GCT technologies, academic medical centers (AMCs) play a crucial role in advancing genetic medicines. However, translating these therapies from bench to clinic requires overcoming numerous challenges, including high costs, complex regulatory pathways, and navigating the translational "valley of death. "To address these challenges, Mass General Brigham's Gene and Cell Therapy Institute (MGB-GCTI) has implemented the RISE model—an institutional framework emphasizing Resource sharing, Interdisciplinary collaboration, Sustainable funding, and Education. In this session speakers will describe the pipeline of latest GCT advancements emerging from academia, including ways AMCs can sustainably incubate GCT development (Dr. Nathan Yozwiak, Head of Research at GCTI).
Read more
2025-03-11 (tovima.gr)
Innovative stem cell therapy is tested in Parkinson's patients -
The Phase I Test that has begun at Boston's Boston's Hospital in Boston concerns the patients' cells in order to replace the dopaminergic neurons of their brain, lost due to the disease
Read more
2024-11-07 (harvard.edu)
Cutting through the fog of long COVID—
Researchers say new AI tool sharpens diagnostic process, may help identify more people needing care.
Read more
2023-09-06 (itnonline.com)
Mass Gen Brigham and GE HealthCare Collaboration Announces AI Algorithm, Radiology Operations Module (ROM), to Optimize Scheduling and Productivity
September 6, 2023 — GE HealthCare and Mass General Brigham have announced, as part of its initial collaboration, the co-development of an artificial intelligence (AI) algorithm that will help increase operations effectiveness and productivity.
Read more
2021-05-10 (healthcareitnews.com)
Mass General Brigham and the future of AI in radiology
The health system's chief data science officer explains how artificial intelligence will assist radiologists – and how it will lead to better patient outcomes.
Read more
(fiercehealthcare.com)
Microsoft collaborates with Mass General Brigham, University of Wisconsin-Madison on AI in medical imaging
Microsoft continues to deepen its work in healthcare AI. | Microsoft continues to deepen its work in healthcare AI. The tech giant is now collaborating with academic medical systems Mass General Brigham and the University of Wisconsin-Madison to advance AI in medical imaging.
Read more
(itnonline.com)
GE HealthCare and Mass General Brigham Evolve Their AI Collaboration with Medical Imaging Foundation Models | Imaging Technology News
March 14, 2024 — Based on its long-term artificial intelligence (AI) partnership,
Read more